KYN

Kyntra Bio, Inc. Common Stock

KYNBNASDAQStock Fundamentals

Kyntra Bio, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Thane Wettig, with a market cap of $27.7M.

Market Cap$27.7M
CEOThane Wettig
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View report
Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

KYN

Kyntra Bio, Inc. Common Stock FAQ

Common questions about Kyntra Bio, Inc. Common Stock

Kyntra Bio, Inc. Common Stock (KYNB) has a market capitalization of $27.7M and trades on NASDAQ.